Brief: Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement
02/02/2026 01:56
Feb 2 (Reuters) - Recce Pharmaceuticals Ltd RCE.AX: RECCE ENTERS SECOND U.S. DEPARTMENT OF DEFENSE RESEARCH AND DEVELOPMENT AGREEMENT AGREEMENT TO ADVANCE RECCE 327 GEL FOR BURN WOUNDS Further company coverage: RCE.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Recce Pharmaceuticals
See all newsBrief: Recce Pharmaceuticals Signs Middle East Licensing Term Sheet
Australia's Reece Pharmaceuticals rises on research and development deal with US Army
Brief: Recce Pharmaceuticals Enters Second U.S. Department Of Defense Research And Development Agreement
Australia's Recce Pharmaceutical hits over 2-yr high on $3.5 million R&D tax rebate
Brief: Recce Pharmaceuticals Awarded Ausindustry Advanced Overseas Finding For Up To A$85M